1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

16 Jul 2020
Admin
News Article

Fosun Pharmas Licensed Covid-19 Vaccine Receives Nmpa Acceptance

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Has Announced That Its Subsidiary Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. Has Received The Acceptance Notice Of Clinical Trial Application For The Licensed Covid-19 Vaccine Product Candidate Bnt162B1 Vaccine. The Clinical Trial Application Of The Vaccine Was Accepted By The National Medical Products Administration (The "Nmpa").Dr. Aimin Hui, Senior Vice President, President Of Global R&Amp;D, And Chief Medical Officer Of Fosun Pharma Said, "Fosun Pharma'S Global R&Amp;D Center Has Been Striving For A Patient-Centered And Clinical-Driven Approach To The Pandemic, And Actively Promoting The International Collaboration With Biontech To Co-Develop An Mrna Vaccine Against The Covid-19. We Hope That The Clinical Trial Will Be Initiated In China As Soon As Possible"In March 2020, Fosun Pharma Has Obtained The License Granted By German Company Biontech Se ("Biontech") To Exclusively Develop And Commercialize Its Vaccine Products Based On Biontech'S Proprietary Mrna Technology Platform Targeting Covid-19 In China. The Vaccine Candidate Is A Prophylactic Biological Product, Aiming At The Precaution Of Covid-19 For People Who Aged 18 Or Above. Biontech Has Announced Interim Analysis Data From An Ongoing Phase 1/2 Study Of Mrna-Based Vaccine Candidate Against Sars-Cov-2, And Its Two Most Advanced Mrna-Based Sars-Cov-2 Vaccine Candidates Bnt162B1 And Bnt162B2 Have Recently Received The Fast Track Designation From The U.S. Food And Drug Administration (Fda). Subject To Approval By Regulatory Authorities, Biontech Expects To Begin A Phase 2B/3 Trial As Early As In Later This Month And Expects Up To 30,000 Subjects To Be Enrolled In The Trial.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!